Abstract
Pulmonary hypertension in obstructive sleep apnea syndrome is common and under recognized. Although more common in patients with OSA associated with chronic lung disease, it is still present in about 20% of patient without co morbid lung or heart disease. Various pathophysiologic changes in OSA especially nocturnal oxygen desaturation, intrathoracic pressure swings, abnormalities in lung mechanics, alteration in ventricular function and rheological changes can contribute to the presence and severity of pulmonary hypertension. The clinical profile in individuals with OSA and pulmonary hypertension are different than in patients with OSA who do not have pulmonary hypertension. Effective treatment of OSA with n CPAP for 12 weeks results in improvement in pulmonary artery pressure.
Keywords: Sleep and pulmonary hypertension, OSA and pulmonary hypertension, sleep and pathophysiology in pulmonary hypertension, CPAP and pulmonary hypertension
Current Respiratory Medicine Reviews
Title: Sleep in Pulmonary Hypertension
Volume: 5 Issue: 4
Author(s): Siva Ramachandran
Affiliation:
Keywords: Sleep and pulmonary hypertension, OSA and pulmonary hypertension, sleep and pathophysiology in pulmonary hypertension, CPAP and pulmonary hypertension
Abstract: Pulmonary hypertension in obstructive sleep apnea syndrome is common and under recognized. Although more common in patients with OSA associated with chronic lung disease, it is still present in about 20% of patient without co morbid lung or heart disease. Various pathophysiologic changes in OSA especially nocturnal oxygen desaturation, intrathoracic pressure swings, abnormalities in lung mechanics, alteration in ventricular function and rheological changes can contribute to the presence and severity of pulmonary hypertension. The clinical profile in individuals with OSA and pulmonary hypertension are different than in patients with OSA who do not have pulmonary hypertension. Effective treatment of OSA with n CPAP for 12 weeks results in improvement in pulmonary artery pressure.
Export Options
About this article
Cite this article as:
Ramachandran Siva, Sleep in Pulmonary Hypertension, Current Respiratory Medicine Reviews 2009; 5 (4) . https://dx.doi.org/10.2174/157339809790112474
DOI https://dx.doi.org/10.2174/157339809790112474 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Network-Based Strategies Can Help Mono- and Poly-pharmacology Drug Discovery: A Systems Biology View
Current Pharmaceutical Design Prevention of Respiratory Syncytial Virus: A Review
Current Respiratory Medicine Reviews Mechanisms of Endothelial Dysfunction: Clinical Significance and Preventive Non-Pharmacological Therapeutic Strategies
Current Pharmaceutical Design New Trends in Thromboxane and Prostacyclin Modulators
Current Medicinal Chemistry The Application of Minerals in Managing Alcohol Hangover: A Preliminary Review
Current Drug Abuse Reviews Magnetomotive Molecular Nanoprobes
Current Medicinal Chemistry Anti-inflammatory and Antioxidant Agents from Salvia Genus (Lamiaceae): An Assessment of the Current State of Knowledge
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Protein Tyrosine Phosphatase 1B Inhibition: Opportunities and Challenges
Current Medicinal Chemistry Juglans regia Seeds have Effects on Platelets and Peripheral Fat Deposition in the Aorta and Heart of C57BL/6J Mice Fed with Normal and High Fat Simple Carbohydrate Diet
Current Nutrition & Food Science Matrix Metalloproteinases: Drug Targets for Myocardial Infarction
Current Drug Targets Vasospastic Angina and Ca Channel Blockers
Current Hypertension Reviews Role of Vascular Progenitor Cells in Cardiovascular Disease
Current Pharmaceutical Design Use of Bromine-76 and Iodine-123 Radiohalogenated Tracers in the Drug Development Process
Current Pharmaceutical Design Oxidative Stress and Endothelial Dysfunction in Cardiovascular Disease: Mitochondria-Targeted Therapeutics
Current Medicinal Chemistry Mitophagy and Disease: New Avenues for Pharmacological Intervention
Current Pharmaceutical Design Statins, Mevalonate Pathway and its Intermediate Products in Placental Development and Preeclampsia
Current Molecular Pharmacology Marine Algae As A Prospective Source For Antidiabetic Compounds – A Brief Review
Current Diabetes Reviews MicroRNAs as Biomarkers in Hypertrophic Cardiomyopathy: Current State of the Art
Current Medicinal Chemistry Increase in the Non-HIV-Related Deaths Among Aids Cases in the HAART Era
Current HIV Research Analysis of QTc Interval during Levofloxacin Prescription in Cardiac Patients with Pneumonia
Current Drug Safety